Visual assessment of diffusion weighted imaging infarct volume lacks accuracy and reliability.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 26 11 2018
revised: 13 01 2019
accepted: 16 01 2019
pubmed: 4 2 2019
medline: 27 11 2019
entrez: 4 2 2019
Statut: ppublish

Résumé

The DAWN trial (Diffusion weighted imaging or CT perfusion Assessment with clinical mismatch in the triage of Wake-up and late presenting strokes undergoing Neurointervention with Trevo) has demonstrated the benefits of thrombectomy in patients with unknown or late onset strokes, using automated software (RAPID) for measurement of infarct volume. Because RAPID is not available in all centers, we aimed to assess the accuracy and repeatability of visual infarct volume estimation by clinicians and the consequences for thrombectomy decisions based on the DAWN criteria. 18 physicians, who routinely depend on MRI for acute stroke imaging, assessed 32 MR scans selected from a prospective databaseover two independent sessions. Raters were asked to visually estimate the diffusion weighted imaging (DWI) infarct volume for each case. Sensitivity, specificity, and accuracy of the estimated volumes were compared with the available RAPID measurements for various volume cut-off points. Thrombectomy decisions based on DAWN criteria with RAPID measurements and raters' visual estimates were compared. Inter-rater and intra-rater agreement was measured using kappa statistics. The mean accuracy of raters was <90% for all volume cut-points. Inter-rater agreement was below substantial for each DWI infarct volume cut-off points. Intra-rater agreement was substantial for 55-83% of raters, depending on the selected cut-off points. Applying DAWN criteria with visual estimates instead of RAPID measurements led to 19% erroneous thrombectomy decisions, and showed a lack of reproducibility. The visual assessment of DWI infarct volume lacks accuracy and repeatability, and could lead to a significant number of erroneous decisions when applying the DAWN criteria.

Identifiants

pubmed: 30712012
pii: neurintsurg-2018-014613
doi: 10.1136/neurintsurg-2018-014613
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

947-954

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Naim Khoury (N)

HSHS Neuroscience Center, HSHS Saint John's Hospital, Springfield, Illinois, USA.

Cyril Dargazanli (C)

Neuroradiology Department, CHRU Gui de CHauliac, Montpellier, France.

Adrien Guenego (A)

Interventional Neuroradiology Department, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

Kevin Zuber (K)

Unit of Clinical Research, Fondation Rothschild Hospital, Paris, France.

Asya Ekmen (A)

Neurology, Hopital Saint-Antoine, Paris, France.

Guillaume Charbonnier (G)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.

Solène Hebert (S)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.

Jean Capron (J)

Neurology, Hopital Saint-Antoine, Paris, France.

Candice Sabben (C)

Neurology, Fondation Rothschild Hospital, Paris, France.

Erwan Morvan (E)

Neurology, Fondation Rothschild Hospital, Paris, France.

William Boisseau (W)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.

Benjamin Maier (B)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.

Kévin Premat (K)

Department of Interventional Neuroradiology, Hôpital de la Pitié-Salpétrière, Paris, France.

Frédéric Clarençon (F)

Department of Interventional Neuroradiology, Hôpital de la Pitié-Salpétrière, Paris, France.

Stanislas Smajda (S)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.

Hocine Redjem (H)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.

Vanessa Chalumeau (V)

Interventional Neuroradiology Department, Hôpital Kremlin-Bicêtre, Le Kremlin-Bicetre, France.

Gregoire Boulouis (G)

Neuroradiology, Sainte-Anne Hospital, Paris, FRANCE.

Annaëlle Chetrit (A)

Radiology, Fondation Rothschild Hospital, Paris, France.

Augustin Lecler (A)

Radiology, Fondation Rothschild Hospital, Paris, France.

Patricia Koskas (P)

Radiology, Fondation Rothschild Hospital, Paris, France.

Loic Duron (L)

Radiology, Fondation Rothschild Hospital, Paris, France.

Gabriele Ciccio (G)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.

Célina Ducroux (C)

Neurology, Hopital Saint-Antoine, Paris, France.

Simon Escalard (S)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.

Jean Philippe Desilles (JP)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.

Mylène Hamdani (M)

Unit of Clinical Research, Fondation Rothschild Hospital, Paris, France.

Bertrand Lapergue (B)

Foch Hospital, Suresnes, France.

Mikael Mazighi (M)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.

Malek Ben Maacha (M)

Unit of Clinical Research, Fondation Rothschild Hospital, Paris, France.

Nahida Brikci-Nigassa (N)

Unit of Clinical Research, Fondation Rothschild Hospital, Paris, France.

Raphael Blanc (R)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.

Michel Piotin (M)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.

Robert Fahed (R)

Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH